Nadia Younan

Suresnes, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Characteristics, outcome, and prognostic factors of young patients with central nervous system World Health Organization grade 3 oligodendrogliomas IDH-mutant and 1p/19q codeleted: A French POLA network study.

Characteristics, outcome, and prognostic factors of young patients with central nervous system World Health Organization grade 3 oligodendrogliomas IDH-mutant and 1p/19q codeleted: A French POLA network study.

Journal: Cancer
Published: November 30, 2024

Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 Oligodendroglioma.

Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 Oligodendroglioma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 02, 2024

T2-Fluid-attenuated inversion recovery (FLAIR) pseudoprogression in patients with anaplastic oligodendrogliomas treated with procarbazine, lomustine and vincristine (PCV) chemotherapy alone.

T2-Fluid-attenuated inversion recovery (FLAIR) pseudoprogression in patients with anaplastic oligodendrogliomas treated with procarbazine, lomustine and vincristine (PCV) chemotherapy alone.

Journal: European journal of neurology
Published: February 27, 2023

Isolated intraocular relapses of primary cerebral lymphomas: An LOC network study.

Isolated intraocular relapses of primary cerebral lymphomas: An LOC network study.

Journal: Hematological oncology
Published: March 08, 2022

Genome-driven medicine for patients with recurrent glioma enrolled in early phase trials.

Genome-driven medicine for patients with recurrent glioma enrolled in early phase trials.

Journal: European journal of cancer (Oxford, England : 1990)
Published: October 24, 2021

Descriptive and retrospective analysis of diffuse glioma patients with symptomatic SARS-CoV2 infection during the first wave of the pandemic.

Descriptive and retrospective analysis of diffuse glioma patients with symptomatic SARS-CoV2 infection during the first wave of the pandemic.

Journal: Neuro-oncology advances
Published: August 16, 2021

Sustained Tumor Control With MAPK Inhibition in BRAF V600-Mutant Adult Glial and Glioneuronal Tumors.

Sustained Tumor Control With MAPK Inhibition in BRAF V600-Mutant Adult Glial and Glioneuronal Tumors.

Journal: Neurology
Published: December 17, 2020

Leptomeningeal Spread in Glioblastoma: Diagnostic and Therapeutic Challenges.

Leptomeningeal Spread in Glioblastoma: Diagnostic and Therapeutic Challenges.

Journal: The oncologist
Published: March 31, 2020

Neurological diseases of unknown etiology: Brain-biopsy diagnostic yields and safety.

Neurological diseases of unknown etiology: Brain-biopsy diagnostic yields and safety.

Journal: European journal of internal medicine
Published: March 16, 2020

Successful Targeting of an ATG7-RAF1 Gene Fusion in Anaplastic Pleomorphic Xanthoastrocytoma With Leptomeningeal Dissemination.

Successful Targeting of an ATG7-RAF1 Gene Fusion in Anaplastic Pleomorphic Xanthoastrocytoma With Leptomeningeal Dissemination.

Journal: JCO precision oncology
Published: December 01, 2019

Mechanisms and therapeutic implications of hypermutation in gliomas.

Mechanisms and therapeutic implications of hypermutation in gliomas.

Journal: Nature
Published: July 22, 2019

Pretreatment Hemoglobin as an Independent Prognostic Factor in Primary Central Nervous System Lymphomas.

Pretreatment Hemoglobin as an Independent Prognostic Factor in Primary Central Nervous System Lymphomas.

Journal: The oncologist
Published: September 25, 2018
Showing 1-12 of 15

Last Updated: 09/26/2026